Ranked by engagement
Top topics — all time page 28
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 28 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Oxidation and deamidation mass shifts, tabulated
Oxidation and deamidation mass shifts, tabulated — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked. retatrutide has a…
|
+34 | 38 | 4.8k | 10mo |
|
About the Site feedback category
Bugs, friction, and the parts of the site that do not work the way you expected. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and…
|
4 | 54k | 10mo | |
|
Second pass at: Transit times by route, from a logged dataset
On the subject in the title: Second pass at: Transit times by route, from a logged dataset Working notes rather than a conclusion. A logistics question, since the answers here are usually better than anywhere…
|
2 | 59k | 19mo | |
|
Request: export my own posts
Posting this under the heading it deserves: Request: export my own posts Everything below is what sits behind that. Nominating something for promotion into the documentation commons. The topic in question…
|
2 | 57k | 6mo | |
|
Cold solution and stinging: the simplest fix
Posting this under the heading it deserves: Cold solution and stinging: the simplest fix Everything below is what sits behind that. Reporting something rather than asking about it, in case the pattern is…
|
+35 | 39 | 8.2k | 30d |
|
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
|
+11 | 15 | 43k | 2mo |
|
What "verified" means on our vendor pages, stated narrowly
What "verified" means on our vendor pages, stated narrowly — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to talk about documentation quality as a…
|
+27 | 31 | 27k | 7mo |
|
Fixed versus detachable needles: the trade-offs — does this still hold?
Fixed versus detachable needles: the trade-offs — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. A question about technique rather than about…
|
+8 | 12 | 39k | 15h |
|
Transit times by route, from a logged dataset
Transit times by route, from a logged dataset Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
|
+34 | 38 | 3.6k | 18h |
|
Oral semaglutide bioavailability and its variability between people
Posting this under the heading it deserves: Oral semaglutide bioavailability and its variability between people Everything below is what sits behind that. I have seen SURMOUNT-4 ( JAMA , 2024) cited in…
|
+44 | 48 | 574 | 3mo |
|
Why I ask for the gradient before I discuss the number
The question in the title: Why I ask for the gradient before I discuss the number I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I…
|
+35 | 39 | 4.9k | 20mo |
|
Coming back to: What the published dose-response for semaglutide actually looks like above 2.4 mg
The question in the title: What the published dose-response for semaglutide actually looks like above 2.4 mg I will give what I have already checked below so nobody repeats it. I have seen LEADER ( N Engl J…
|
+23 | 27 | 9.9k | 1mo |
|
Coming back to: Telehealth prescribing models in the US
Posting this under the heading it deserves: Telehealth prescribing models in the US Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
+26 | 30 | 17k | 17h |
|
Vagal afferents and the gut-brain pathway
On the subject in the title: Vagal afferents and the gut-brain pathway Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in front of me that…
|
+5 | 9 | 44k | 13mo |
|
Journal club: SELECT, absolute risk, and how it was reported
Journal club: SELECT, absolute risk, and how it was reported Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med , 2024). Please read…
|
2 | 52k | 1mo | |
|
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
|
+5 | 9 | 45k | 4mo |
|
Severe gastroparesis and why this class is a poor fit — one year on
Severe gastroparesis and why this class is a poor fit — one year on — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
|
+19 | 23 | 23k | 7mo |
|
Turnaround times and what they mean for a decision — one year on
On the subject in the title: Turnaround times and what they mean for a decision — one year on Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+25 | 29 | 22k | 18mo |
|
A parcel stationary at a customs facility for nine days — does this still hold?
The question in the title: A parcel stationary at a customs facility for nine days — does this still hold? I will give what I have already checked below so nobody repeats it. A logistics question, since the…
|
+23 | 27 | 12k | 1mo |
|
Tirzepatide's shorter half-life and its one practical consequence
On the subject in the title: Tirzepatide's shorter half-life and its one practical consequence Working notes rather than a conclusion. I have seen SELECT ( N Engl J Med , 2023) cited in support of a claim I…
|
+18 | 29 | 20k | 8mo |
|
Isotonicity and what happens when you get it wrong
On the subject in the title: Isotonicity and what happens when you get it wrong Working notes rather than a conclusion. Posting the method first, because I know what the first three replies will otherwise be.…
|
+27 | 31 | 11k | 18mo |
|
Column chemistry choices for a 40-residue peptide
Column chemistry choices for a 40-residue peptide — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies will otherwise be.…
|
+39 | 43 | 1.1k | 10mo |
|
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one — setting out what I have, and where I think it stops being reliable. Session topic: FLOW ( N Engl J Med , 2024). Please…
|
+25 | 29 | 22k | 1d |
|
About the Regulatory category
Research-use-only status, compounding rules, import restrictions, and the primary documents behind them. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
|
4 | 49k | 4mo | |
|
Coming back to: Reading a supplier's product description as a marketing document
Reading a supplier's product description as a marketing document Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in…
|
+35 | 39 | 688 | 5mo |
|
Follow-up: Oral contraceptives and delayed emptying: what the data shows
Oral contraceptives and delayed emptying: what the data shows — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern is…
|
+31 | 35 | 13k | 18mo |
|
Selection into a registry and what it does to the estimate
Selection into a registry and what it does to the estimate — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it before posting; the…
|
2 | 55k | 7mo | |
|
Reimbursement variation across member states
Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
|
+7 | 11 | 39k | 3mo |
|
Albumin binding and how it produces a long half-life
Albumin binding and how it produces a long half-life — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it anywhere. A…
|
+38 | 44 | 6.6k | 14mo |
|
GLP-1 receptor distribution: central and peripheral — one year on
GLP-1 receptor distribution: central and peripheral — one year on — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
|
+7 | 11 | 43k | 3mo |